

Part 1
Part 2
Part 3
Part 5
Description
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. The global market for Giant Cell Arteritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Giant Cell Arteritis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Giant Cell Arteritis Treatment by region & country, by Type, and by Application.
The Giant Cell Arteritis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Giant Cell Arteritis Treatment.
Market Segmentation
Report Metric
Details
Report Title
Giant Cell Arteritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Giant Cell Arteritis Treatment Companies Covered
Johns Hopkins Hospital, Fortis Healthcare, American College of Rheumatology, Duke University Health System, Lahey Clinic Foundation
Global Giant Cell Arteritis Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Giant Cell Arteritis Treatment Market, Segment by Type
Corticosteroid Therapy
Adjuvant Agents
Global Giant Cell Arteritis Treatment Market, Segment by Application
Hospitals
Clinics
ASCs
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Giant Cell Arteritis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Giant Cell Arteritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Giant Cell Arteritis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Giant Cell Arteritis Treatment Product Introduction
1.2 Global Giant Cell Arteritis Treatment Market Size Forecast
1.3 Giant Cell Arteritis Treatment Market Trends & Drivers
1.3.1 Giant Cell Arteritis Treatment Industry Trends
1.3.2 Giant Cell Arteritis Treatment Market Drivers & Opportunity
1.3.3 Giant Cell Arteritis Treatment Market Challenges
1.3.4 Giant Cell Arteritis Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered2 Competitive Analysis by Company
2.1 Global Giant Cell Arteritis Treatment Players Revenue Ranking (2023)
2.2 Global Giant Cell Arteritis Treatment Revenue by Company (2019-2024)
2.3 Key Companies Giant Cell Arteritis Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Giant Cell Arteritis Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Giant Cell Arteritis Treatment
2.6 Giant Cell Arteritis Treatment Market Competitive Analysis
2.6.1 Giant Cell Arteritis Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Giant Cell Arteritis Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Corticosteroid Therapy
3.1.2 Adjuvant Agents
3.2 Global Giant Cell Arteritis Treatment Sales Value by Type
3.2.1 Global Giant Cell Arteritis Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Giant Cell Arteritis Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Giant Cell Arteritis Treatment Sales Value, by Type (%) (2019-2030)4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 ASCs
4.1.4 Others
4.2 Global Giant Cell Arteritis Treatment Sales Value by Application
4.2.1 Global Giant Cell Arteritis Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Giant Cell Arteritis Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Giant Cell Arteritis Treatment Sales Value, by Application (%) (2019-2030)5 Segmentation by Region
5.1 Global Giant Cell Arteritis Treatment Sales Value by Region
5.1.1 Global Giant Cell Arteritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Giant Cell Arteritis Treatment Sales Value by Region (2019-2024)
5.1.3 Global Giant Cell Arteritis Treatment Sales Value by Region (2025-2030)
5.1.4 Global Giant Cell Arteritis Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Giant Cell Arteritis Treatment Sales Value, 2019-2030
5.2.2 North America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Giant Cell Arteritis Treatment Sales Value, 2019-2030
5.3.2 Europe Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Giant Cell Arteritis Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Giant Cell Arteritis Treatment Sales Value, 2019-2030
5.5.2 South America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Giant Cell Arteritis Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 20306 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Giant Cell Arteritis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Giant Cell Arteritis Treatment Sales Value
6.3 United States
6.3.1 United States Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.3.2 United States Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.4.2 Europe Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.5.2 China Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.6.2 Japan Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.7.2 South Korea Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Giant Cell Arteritis Treatment Sales Value, 2019-2030
6.9.2 India Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Giant Cell Arteritis Treatment Sales Value by Application, 2023 VS 20307 Company Profiles
7.1 Johns Hopkins Hospital
7.1.1 Johns Hopkins Hospital Profile
7.1.2 Johns Hopkins Hospital Main Business
7.1.3 Johns Hopkins Hospital Giant Cell Arteritis Treatment Products, Services and Solutions
7.1.4 Johns Hopkins Hospital Giant Cell Arteritis Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Johns Hopkins Hospital Recent Developments
7.2 Fortis Healthcare
7.2.1 Fortis Healthcare Profile
7.2.2 Fortis Healthcare Main Business
7.2.3 Fortis Healthcare Giant Cell Arteritis Treatment Products, Services and Solutions
7.2.4 Fortis Healthcare Giant Cell Arteritis Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Fortis Healthcare Recent Developments
7.3 American College of Rheumatology
7.3.1 American College of Rheumatology Profile
7.3.2 American College of Rheumatology Main Business
7.3.3 American College of Rheumatology Giant Cell Arteritis Treatment Products, Services and Solutions
7.3.4 American College of Rheumatology Giant Cell Arteritis Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Duke University Health System Recent Developments
7.4 Duke University Health System
7.4.1 Duke University Health System Profile
7.4.2 Duke University Health System Main Business
7.4.3 Duke University Health System Giant Cell Arteritis Treatment Products, Services and Solutions
7.4.4 Duke University Health System Giant Cell Arteritis Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Duke University Health System Recent Developments
7.5 Lahey Clinic Foundation
7.5.1 Lahey Clinic Foundation Profile
7.5.2 Lahey Clinic Foundation Main Business
7.5.3 Lahey Clinic Foundation Giant Cell Arteritis Treatment Products, Services and Solutions
7.5.4 Lahey Clinic Foundation Giant Cell Arteritis Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Lahey Clinic Foundation Recent Developments8 Industry Chain Analysis
8.1 Giant Cell Arteritis Treatment Industrial Chain
8.2 Giant Cell Arteritis Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Giant Cell Arteritis Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Giant Cell Arteritis Treatment Distributors9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Giant Cell Arteritis Treatment Market Trends
Table 2. Giant Cell Arteritis Treatment Market Drivers & Opportunity
Table 3. Giant Cell Arteritis Treatment Market Challenges
Table 4. Giant Cell Arteritis Treatment Market Restraints
Table 5. Global Giant Cell Arteritis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Giant Cell Arteritis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Giant Cell Arteritis Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Giant Cell Arteritis Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Giant Cell Arteritis Treatment
Table 10. Global Giant Cell Arteritis Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Giant Cell Arteritis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Giant Cell Arteritis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Giant Cell Arteritis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Giant Cell Arteritis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Giant Cell Arteritis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Giant Cell Arteritis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Giant Cell Arteritis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Giant Cell Arteritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Giant Cell Arteritis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Giant Cell Arteritis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Giant Cell Arteritis Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Giant Cell Arteritis Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Johns Hopkins Hospital Basic Information List
Table 32. Johns Hopkins Hospital Description and Business Overview
Table 33. Johns Hopkins Hospital Giant Cell Arteritis Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Johns Hopkins Hospital (2019-2024)
Table 35. Johns Hopkins Hospital Recent Developments
Table 36. Fortis Healthcare Basic Information List
Table 37. Fortis Healthcare Description and Business Overview
Table 38. Fortis Healthcare Giant Cell Arteritis Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Fortis Healthcare (2019-2024)
Table 40. Fortis Healthcare Recent Developments
Table 41. American College of Rheumatology Basic Information List
Table 42. American College of Rheumatology Description and Business Overview
Table 43. American College of Rheumatology Giant Cell Arteritis Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of American College of Rheumatology (2019-2024)
Table 45. American College of Rheumatology Recent Developments
Table 46. Duke University Health System Basic Information List
Table 47. Duke University Health System Description and Business Overview
Table 48. Duke University Health System Giant Cell Arteritis Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Duke University Health System (2019-2024)
Table 50. Duke University Health System Recent Developments
Table 51. Lahey Clinic Foundation Basic Information List
Table 52. Lahey Clinic Foundation Description and Business Overview
Table 53. Lahey Clinic Foundation Giant Cell Arteritis Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Giant Cell Arteritis Treatment Business of Lahey Clinic Foundation (2019-2024)
Table 55. Lahey Clinic Foundation Recent Developments
Table 56. Key Raw Materials Lists
Table 57. Raw Materials Key Suppliers Lists
Table 58. Giant Cell Arteritis Treatment Downstream Customers
Table 59. Giant Cell Arteritis Treatment Distributors List
Table 60. Research Programs/Design for This Report
Table 61. Key Data Information from Secondary Sources
Table 62. Key Data Information from Primary Sources
Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Giant Cell Arteritis Treatment Product Picture
Figure 2. Global Giant Cell Arteritis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Giant Cell Arteritis Treatment Report Years Considered
Figure 5. Global Giant Cell Arteritis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Giant Cell Arteritis Treatment Revenue in 2023
Figure 7. Giant Cell Arteritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Corticosteroid Therapy Picture
Figure 9. Adjuvant Agents Picture
Figure 10. Global Giant Cell Arteritis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Giant Cell Arteritis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Clinics
Figure 14. Product Picture of ASCs
Figure 15. Product Picture of Others
Figure 16. Global Giant Cell Arteritis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Giant Cell Arteritis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Giant Cell Arteritis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Giant Cell Arteritis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Giant Cell Arteritis Treatment Sales Value (%), (2019-2030)
Figure 29. United States Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. China Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. China Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. India Giant Cell Arteritis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Giant Cell Arteritis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. India Giant Cell Arteritis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. Giant Cell Arteritis Treatment Industrial Chain
Figure 51. Giant Cell Arteritis Treatment Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Description
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. The global market for Giant Cell Arteritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Giant Cell Arteritis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Giant Cell Arteritis Treatment by region & country, by Type, and by Application.
The Giant Cell Arteritis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Giant Cell Arteritis Treatment.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Giant Cell Arteritis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Giant Cell Arteritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Giant Cell Arteritis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now